10Objective: To assess the efficiency of the carbon nanoparticles (CNs) in lymph node identification 11 and parathyroid gland protection during thyroidectomy. 12 Methods: A systematic literature search for relevant literatures published up to December 2018 in 13 PubMed, Embase, Web of Science and Cochrane Library was performed. Both English and Chinese 14 literatures were retrieved and analyzed. Randomized controlled trials or nonrandomized controlled 15 trials on the use of CNs during thyroidectomy were enrolled in this study. The primary outcomes 16 included the number of lymph nodes harvesed, rate of lymph nodes involvement, and the rates of 17 accidental parathyroidectomy, hypoparathyroidism, and hypocalcemia. Weighted mean differences 18 (WMDs), odds ratios (ORs) and risk differences (RDs) were calculated for the dichotomous 19 outcome variables. Between-study heterogeneity was tested using the Q tests and the I 2 statistics.
20All analyses were performed using Review Manager (version 5.3.5).
21Results: 25 studies comprising 3266 patients were included in this analysis. The total number of 22 lymph nodes harvested in the groups of carbon nanoparticles was significant higher than that in the 32
Conclusions:The application of CNs for thyroidectomy results in higher number of lymph node 33 harvested and better parathyroid gland protection during initial surgery and reoperation for thyroid 34 cancer.
35